The controlling shareholder of Novo Nordisk has joined a coalition of European venture capital firms to mobilise increased funding amidst concerns that Europe’s life sciences sector may fall behind its
The controlling shareholder of Novo Nordisk has joined a coalition of European venture capital firms to mobilise increased funding amidst concerns that Europe’s life sciences sector may fall behind its






